retatrutide obesity treatment clinical trial information Safety, Side Effects & Provider Use Retatrutide Dosing: Early Clinical Trial – When will Retatrutide be available

Phase 3 trials are ongoing as of 2026, and the compound is not yet approved for clinical use it remains a research compound in active late-phase development

As shown in clinical trials, these medications work in several ways: they may help reduce appetite, slow the rate at which your stomach empties, and support blood sugar regulation

Cell 180 , 373386 (2020)

Swimming counts

The XR (extended-release) formulation is specifically designed to release metformin slowly over 24 hours

So imagine my cognitive dissonance getting shocked when Eli Lilly not only showed that Amylin can play in the sandbox with the big multi-agonists, but that it can do so with perhaps more tolerable side effects